37 results on '"Kaplan, Robert C"'
Search Results
2. Genetic Variants Related to Height and Risk of Atrial Fibrillation.
- Author
-
Rosenberg, Michael A., Kaplan, Robert C., Siscovick, David S., Psaty, Bruce M., Heckbert, Susan R., Newton-Cheh, Christopher, and Mukamal, Kenneth J.
- Subjects
- *
ATRIAL fibrillation risk factors , *ANALYSIS of variance , *CHI-squared test , *CONFIDENCE intervals , *STATISTICAL correlation , *ELECTROCARDIOGRAPHY , *GENETIC polymorphisms , *LONGITUDINAL method , *REFERENCE values , *RESEARCH funding , *STATISTICS , *STATURE , *DATA analysis , *SECONDARY analysis , *DISCHARGE planning , *PREDICTIVE validity , *DISEASE incidence , *REPEATED measures design , *PROPORTIONAL hazards models , *DESCRIPTIVE statistics - Abstract
Increased height is a known independent risk factor for atrial fibrillation (AF). However, whether genetic determinants of height influence risk is uncertain. In this candidate gene study, we examined the association of 209 height-associated single-nucleotide polymorphisms (SNPs) with incident AF in 3,309 persons of European descent from the Cardiovascular Health Study, a prospective cohort study of older adults (aged ≥65 years) enrolled in 1989–1990. After a median follow-up period of 13.2 years, 879 participants developed incident AF. The height-associated SNPs together explained approximately 10% of the variation in height (P = 6.0 × 10−8). Using an unweighted genetic height score, we found a nonsignificant association with risk of AF (per allele, hazard ratio = 1.01, 95% confidence interval: 1.00, 1.02; P = 0.06). In weighted analyses, we found that genetically predicted height was strongly associated with AF risk (per 10 cm, hazard ratio = 1.30, 95% confidence interval: 1.03, 1.64; P = 0.03). Importantly, for all models, the inclusion of actual height completely attenuated the genetic height effect. Finally, we identified 1 nonsynonymous SNP (rs1046934) that was independently associated with AF and may warrant future study. In conclusion, we found that genetic determinants of height appear to increase the risk of AF, primarily via height itself. This approach of examining SNPs associated with an intermediate phenotype should be considered as a method for identifying novel genetic targets. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
3. T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women.
- Author
-
Kaplan, Robert C., Sinclair, Elizabeth, Landay, Alan L., Lurain, Nell, Sharrett, A. Richey, Gange, Stephen J., Xiaonan Xue, Hunt, Peter, Karim, Roksana, Kern, David M., Hodis, Howard N., and Deeks, Steven G.
- Subjects
- *
CAROTID artery diseases , *HIV-positive women , *T cells , *MULTIVARIATE analysis , *ANTIRETROVIRAL agents , *OLD age - Abstract
Background. Individuals infected with human immunodeficiency virus (HIV) have increased risk of cardiovascular events. It is unknown whether T cell activation and senescence, 2 immunologic sequelae of HIV infection, are associated with vascular disease among HIV-infected adults. Methods. T cell phenotyping and carotid ultrasound were assessed among 115 HIV-infected women and 43 age- and race/ethnicity-matched HIV-uninfected controls participating in the Women's Interagency HIV Study. Multivariate analyses were used to assess the association of T cell activation (CD38+HLA-DR+) and senescence (CD28-CD57+) with subclinical carotid artery disease. Results. Compared with HIV-uninfected women, frequencies of CD4+CD38+HLA-DR+, CD8+CD38+HLA-DR+, and CD8+CD28-CD57+ T cells were higher among HIV-infected women, including those who achieved viral suppression while receiving antiretroviral treatment. Among HIV-infected women, adjusted for age, antiretroviral medications, and viral load, higher frequencies of activated CD4+ and CD8+ T cells and immunosenescent CD8+ T cells were associated with increased prevalence of carotid artery lesions (prevalence ratiolesions associated with activated CD4+ T cells, 1.6 per SD [95% confidence interval {CI}, 1.1-2.2]; P 5 .02; prevalence ratiolesions associated with activated CD8+ T cells, 2.0 per SD [95% CI, 1.2-3.3]; P < .01; prevalence ratiolesions associated with senescent CD8+ T cells, 1.9 per SD [95% CI, 1.1-3.1]; P = .01). Conclusions. HIV-associated T cell changes are associated with subclinical carotid artery abnormalities, which may be observed even among those patients achieving viral suppression with effective antiretroviral therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
4. Insulin-Like Growth Factors and Leukocyte Telomere Length: The Cardiovascular Health Study.
- Author
-
Kaplan, Robert C., Fitzpatrick, Annette L., Pollak, Michael N., Gardner, Jeffrey P., Jenny, Nancy S., McGinn, Aileen P., Kuller, Lewis H., Strickler, Howard D., Kimura, Masayuki, Psaty, Bruce M., and Aviv, Abraham
- Subjects
- *
INSULIN , *TELOMERES , *LEUCOCYTES , *IMMUNOLOGY , *CARDIOLOGY , *GROWTH factors , *AGING - Abstract
The insulin-like growth factor (IGF) axis may affect immune cell replicative potential and telomere dynamics. Among 551 adults 65 years and older, leukocyte telomere length (LTL), insulin-like growth factor-1 (IGF-1), and insulin-like growth factor–binding proteins 1 and 3 (IGFBP-1, IGFBP-3) were measured. Multivariate linear regression was used to model the association of LTL with IGF-1 and IGFBPs, while controlling for confounding and increasing precision by adjusting for covariates. We observed a significant association between higher IGF-1 and longer LTL after adjustment for age, sex, race, smoking status, body mass index, hypertension, diabetes, and serum lipids. The results suggested an increase of .08 kb in LTL for each standard deviation increase of IGF-1 (p = .04). IGFBP-1 and IGFBP-3 were not significantly associated with LTL. High IGF-1 may be an independent predictor of longer LTL, consistent with prior evidence suggesting a role for IGF-1 in mechanisms relating to telomere maintenance. [ABSTRACT FROM PUBLISHER]
- Published
- 2009
- Full Text
- View/download PDF
5. Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women.
- Author
-
Kaplan, Robert C., Kingsley, Lawrence A., Sharrett, A. Richey, Xiuhong Li, Lazar, Jason, Tien, Phyllis C., Mack, Wendy J., Cohen, Mardge H., Jacobson, Lisa, and Gange, Stephen J.
- Subjects
- *
CORONARY disease , *HIV-positive women , *HIV-positive men , *HIV , *LIPIDS , *BLOOD pressure measurement , *HIV infections , *HIGHLY active antiretroviral therapy , *MEDICAL sciences - Abstract
Background. Highly active antiretroviral therapy (HAART), in addition to traditional vascular risk factors, may affect coronary heart disease (CHD) risk in individuals with human immunodeficiency virus (HIV) infection. Methods. Among HIV-infected (931 men and 1455 women) and HIV-uninfected (1099 men and 576 women) adults, the predicted risk of CHD was estimated on the basis of age, sex, lipid and blood pressure levels, the presence of diabetes, and smoking status. Results. Among HIV-infected men, 2% had moderate predicted risk of CHD (10-year CHD risk, 15%-25%), and 17% had high predicted risk (10-year CHD risk of ⩾25% or diabetes). Among HIV-infected women, 2% had moderate predicted CHD risk, and 12% had high predicted CHD risk. Compared with users of protease inhibitor- based HAART, the adjusted odds ratio (OR) for moderate-to-high risk of CHD was significantly lower among HAART-naive individuals (OR, 0.57; 95% confidence interval [CI], 0.36-0.89). Users of HAART that was not protease inhibitor based (OR, 0.74; 95% CI, 0.53-1.01) and former HAART users (OR, 0.68; 95% CI, 0.46-1.03) were also less likely than users of protease inhibitor-based HAART to have moderate-to-high CHD risk, although 95% CIs overlapped the null. Low income was associated with increased likelihood of moderate-to-high CHD risk (for annual income <$10,000 vs. >$40,000: OR, 2.32; 95% CI, 1.51-3.56 ). Elevated body mass index (calculated as weight in kilograms divided by the square of height in meters) predicted increased likelihood of moderate-to- high CHD risk (for BMI of 18.5-24.9 vs. BMI of 25-30: OR, 1.41 [95% CI, 1.03-1.93]; for BMI of 18.5-24.9 vs. BMI ⩾30: OR, 1.79 [95% CI, 1.25-2.56]). Conclusions. Among HIV-infected adults, in addition to antiretroviral drug exposures, being overweight and having a low income level were associated with increased predicted CHD risk. This suggests a need to target HIV- infected men and women with these characteristics for vascular risk factor screening. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
6. Letters to the Editor.
- Author
-
Kaplan, Robert C., Heckbert, Susan R., Koepsell, Thomas D., Rosendaal, Frits R., Furberg, Curt D., Cooper, Lawton S., Psaty, Bruce M., Strain, W. David, Lye, Michael, Schoevaerdts, Didier, Sax, Hugo, Gavazzi, Gaetan, Perrenoud, Jean-Jacques, Michel, Jean-Pierre, and Sieber, Cornel C.
- Subjects
- *
GERIATRICS , *CHRONIC pain , *ENDOCARDITIS , *GASTROINTESTINAL system injuries - Abstract
Discusses several topics related to geriatrics research. Calcium channel blocker use and gastrointestinal tract bleeding among older adults; Chronic pain and bereavement in a depressed elderly woman; Endocarditis in older people.
- Published
- 2002
7. Subclinical Atherosclerosis Across the Menopausal Transition in Women With and Without HIV.
- Author
-
Peters, Brandilyn A, Whalen, Adam, Xue, Xiaonan, Topper, Elizabeth F, Weber, Kathleen M, Tien, Phyllis C, Kassaye, Seble G, Minkoff, Howard, Fox, Ervin, Fischl, Margaret A, Collins, Lauren F, Floris-Moore, Michelle, Hodis, Howard N, Qi, Qibin, Hanna, David B, Sharma, Anjali, Anastos, Kathryn, and Kaplan, Robert C
- Abstract
The menopausal transition is a pivotal time of cardiovascular risk, but knowledge is limited in HIV. We studied longitudinal carotid artery intima-media thickness (CIMT) in the Women's Interagency HIV Study (2004–2019; 979 women/3247 person-visits; 72% with HIV). Among women with HIV only, those who transitioned had greater age-related CIMT progression compared to those remaining premenopausal (difference in slope = 1.64 µm/year, P =.002); and CIMT increased over time in the pretransition (3.47 µm/year, P =.002) and during the menopausal transition (9.41 µm/year, P <.0001), but not posttransition (2.9 µm/year, P =.19). In women with HIV, menopause may accelerate subclinical atherosclerosis as measured by CIMT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. The Association Between Ankle–Brachial Index and Daily Patterns of Physical Activity: Results From the Hispanic Community Health Study/Study of Latinos.
- Author
-
Chiu, Venus, Urbanek, Jacek K, Wanigatunga, Amal A, Allison, Matthew A, Ballew, Shoshana H, Mossavar-Rahmani, Yasmin, Sotres-Alvarez, Daniela, Gallo, Linda C, Xue, Xiaonan, Talavera, Gregory A, Evenson, Kelly R, Kaplan, Robert C, Matsushita, Kunihiro, and Schrack, Jennifer A
- Subjects
- *
HEALTH of Hispanic Americans , *PHYSICAL activity , *ANKLE brachial index , *PERIPHERAL vascular diseases , *PUBLIC health - Abstract
Background Peripheral artery disease (PAD) is associated with lower physical activity but less is known about its association with daily patterns of activity. We examined the cross-sectional association between ankle–brachial index (ABI) and objectively measured patterns of physical activity among Hispanic/Latino adults. Methods We analyzed data from 7 688 participants (aged 45–74 years) in the Hispanic Community Health Study/Study of Latinos. ABI was categorized as low (≤0.90, indicating PAD), borderline low (0.91–0.99), normal (1.00–1.40), and high (>1.40, indicating incompressible ankle arteries). Daily physical activity metrics derived from accelerometer data included: log of total activity counts (LTAC), total log-transformed activity counts (TLAC), and active-to-sedentary transition probability (ASTP). Average differences between ABI categories in physical activity, overall and by 4-hour time-of-day intervals, were assessed using linear regression and mixed-effects models, respectively. Results In Hispanic/Latino adults, 5.3% and 2.6% had low and high ABIs, respectively. After adjustment, having a low compared to a normal ABI was associated with lower volume (LTAC = −0.13, p <.01; TLAC = −74.4, p =.04) and more fragmented physical activity (ASTP = 1.22%, p <.01). Having a low ABI was linked with more fragmented physical activity after 12 pm (p <.01). Having a high ABI was associated with lower volumes of activity (TLAC = −132.0, p =.03). Conclusions Having a low or high ABI is associated with lower and more fragmented physical activity in Hispanic/Latino adults. In adults with low ABI, physical activity is more fragmented in the afternoon to evening. Longitudinal research is warranted to expand these findings to guide targeted interventions for PAD or incompressible ankle arteries. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Childhood and Life-Course Socioeconomic Position and Cognitive Function in the Adult Population of the Hispanic Community Health Study/Study of Latinos.
- Author
-
Filigrana, Paola, Moon, Jee-Young, Gallo, Linda C, Fernández-Rhodes, Lindsay, Perreira, Krista M, Daviglus, Martha L, Thyagarajan, Bharat, Garcia-Bedoya, Olga L, Cai, Jianwen, Lipton, Richard B, Kaplan, Robert C, Gonzalez, Hector M, and Isasi, Carmen R
- Subjects
- *
ADVERSE childhood experiences , *LIFE change events , *MID-life crisis , *CONFIDENCE intervals , *HISPANIC Americans , *HEALTH status indicators , *REGRESSION analysis , *SOCIOECONOMIC factors , *INCOME , *SURVEYS , *FACTOR analysis , *DESCRIPTIVE statistics , *RESEARCH funding , *COGNITIVE testing , *EDUCATIONAL attainment - Abstract
The Hispanic/Latino population experiences socioeconomic adversities across the lifespan and is at greater risk of cognitive impairment, yet little is known about the role of life-course socioeconomic position (SEP) in cognitive function in this population. Using baseline data (2008–2011) from adults (aged 45–74 years) of the Hispanic Community Health Study/Study of Latinos, we assessed the association between childhood SEP and socioeconomic mobility with cognitive function, and whether this association was mediated by midlife SEP. Childhood SEP was assessed using parental education. An index combining participants' education and household income represented midlife SEP. Socioeconomic mobility was categorized as stable low, downward or upward mobility, and stable high-SEP. Cognitive function measures were modeled using survey linear regression with inverse-probability weighting, accounting for covariates. We used mediation analysis to estimate the indirect effect of childhood SEP on cognition through midlife SEP. High childhood SEP was associated with global cognition in adulthood (coefficient for parental education beyond high school vs. less than high school = 0.26, 95% confidence interval: 0.15, 0.37). This association was partially mediated through midlife SEP (indirect effect coefficient = 0.16, 95% confidence interval: 0.15, 0.18). Low SEP through the life course was associated with the lowest cognitive function. This study provides evidence that life-course SEP influences cognitive performance in adulthood. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Sex- and Poverty-Specific Patterns in Cardiovascular Disease Mortality Associated With Human Immunodeficiency Virus, New York City, 2007–2017.
- Author
-
Hanna, David B, Ramaswamy, Chitra, Kaplan, Robert C, Kizer, Jorge R, Daskalakis, Demetre, Anastos, Kathryn, and Braunstein, Sarah L
- Subjects
- *
HIV infection complications , *CONFIDENCE intervals , *HIV , *HIV-positive persons , *POVERTY , *RNA viruses , *SEX distribution , *T cells , *ODDS ratio ,CARDIOVASCULAR disease related mortality - Abstract
Background Human immunodeficiency virus (HIV) may affect the risk of death due to cardiovascular disease (CVD) differently in men versus women. Methods We examined CVD mortality rates between 2007 and 2017 among all New York City residents living with HIV and aged 13+ by sex, using data from city HIV surveillance and vital statistics and the National Death Index. Residents without HIV were enumerated using modified US intercensal estimates. We determined associations of HIV status with CVD mortality by sex and neighborhood poverty, defined as the percent of residents living below the federal poverty level, after accounting for age, race/ethnicity, and year. Results There were 3234 CVD deaths reported among 147 915 New Yorkers living with HIV, with the proportion of deaths due to CVD increasing from 11% in 2007 to 22% in 2017. The age-standardized CVD mortality rate was 2.7/1000 person-years among both men and women with HIV. The relative rate of CVD mortality associated with HIV status was significantly higher among women (adjusted rate ratio [aRR] 1.7, 95% confidence interval [CI] 1.6–1.8) than men (aRR 1.2, 95% CI 1.1–1.3) overall, and within strata defined by neighborhood poverty. Sex differences in CVD mortality rates were the greatest when comparing individuals living with HIV and having detectable HIV RNA and CD4+ T-cell counts <500 cells/uL with individuals living without HIV. Conclusions Among people with HIV, 1 in 5 deaths is now associated with CVD. HIV providers should recognize the CVD risk among women with HIV, and reinforce preventive measures (eg, smoking cessation, blood pressure control, lipid management) and viremic control among people living with HIV regardless of neighborhood poverty to reduce CVD mortality. Human immunodeficiency virus (HIV) increases cardiovascular disease mortality risks to a greater degree among women than men, even after accounting for neighborhood poverty. HIV providers should emphasize cardiovascular disease prevention (eg, smoking cessation, hypertension control, lipid management) and viremic control. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Nutritional Blood Concentration Biomarkers in the Hispanic Community Health Study/Study of Latinos: Measurement Characteristics and Power.
- Author
-
Boe, Lillian A, Mossavar-Rahmani, Yasmin, Sotres-Alvarez, Daniela, Daviglus, Martha L, Durazo-Arvizu, Ramon A, Thyagarajan, Bharat, Kaplan, Robert C, and Shaw, Pamela A
- Subjects
- *
BIOMARKERS , *EVALUATION of medical care , *NUTRITIONAL assessment , *VITAMIN B12 , *HISPANIC Americans , *MULTIVARIATE analysis , *COMMUNITY health services , *CAROTENOIDS , *PHYSICAL activity , *DESCRIPTIVE statistics , *VITAMIN A , *TRACE elements , *FOLIC acid , *MEASUREMENT errors , *LONGITUDINAL method - Abstract
Measurement error is a major issue in self-reported diet that can distort diet-disease relationships. Use of blood concentration biomarkers has the potential to mitigate the subjective bias inherent in self-reporting. As part of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) baseline visit (2008–2011), self-reported information on diet was collected from all participants (n = 16,415). The HCHS/SOL also included annual telephone follow-up, as well as a second (2014–2017) and third (2020–2023) clinic visit. Blood concentration biomarkers for carotenoids, tocopherols, retinol, vitamin B12, and folate were measured in a subset of participants (n = 476) as part of the Study of Latinos: Nutrition and Physical Activity Assessment Study (SOLNAS) (2010–2012). We examined the relationships among biomarker levels, self-reported intake, Hispanic/Latino background (Central American, Cuban, Dominican, Mexican, Puerto Rican, or South American), and other participant characteristics in this diverse cohort. We built regression calibration–based prediction equations for 10 nutritional biomarkers and used a simulation to study the power of detecting a diet-disease association in a multivariable Cox model using a predicted concentration level. Good statistical power was observed for some nutrients with high prediction model R 2 values, but further research is needed to understand how best to realize the potential of these dietary biomarkers. This study provides a comprehensive examination of several nutritional biomarkers within the HCHS/SOL, characterizing their associations with subject characteristics and the influence of the measurement characteristics on the power to detect associations with health outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus.
- Author
-
Peters, Brandilyn A, Hanna, David B, Sharma, Anjali, Anastos, Kathryn, Hoover, Donald R, Shi, Qiuhu, Moran, Caitlin A, Jackson, Elizabeth A, Alcaide, Maria L, Ofotokun, Igho, Adimora, Adaora A, Haberlen, Sabina A, Cohen, Mardge, Tien, Phyllis C, Michel, Katherine G, Levine, Steven R, Hodis, Howard N, Kaplan, Robert C, and Yin, Michael T
- Subjects
- *
HORMONE therapy , *CONFIDENCE intervals , *WOMEN , *ATHEROSCLEROSIS , *MENOPAUSE , *HIV - Abstract
Background Estrogen-based hormone therapy (HT) may have beneficial cardiovascular effects when initiated in early menopause. This has not been examined in women with human immunodeficiency virus (HIV), who have heightened immune activation and cardiovascular risks. Methods Among 609 postmenopausal women (1234 person-visits) in the Women's Interagency HIV Study, we examined the relationship of ever HT use (oral, patch, or vaginal) with subclinical atherosclerosis: carotid artery intima-media thickness (CIMT), distensibility, and plaque assessed via repeated B-mode ultrasound imaging (2004–2013). We also examined associations of HT with cross-sectional biomarkers of immune activation and D-dimer. Statistical models were adjusted for sociodemographic, behavioral, and cardiometabolic factors. Results Women (mean age, 51 years; 80% HIV positive) who ever used HT at baseline were older, and more likely to be non-Hispanic White and report higher income, than never-users. Women who ever used HT had 43% lower prevalence of plaque (prevalence ratio, 0.57 [95% confidence interval {CI},.40–.80]; P <.01), 2.51 µm less progression of CIMT per year (95% CI, –4.60, to –.41; P =.02), and marginally lower incidence of plaque over approximately 7 years (risk ratio, 0.38 [95% CI,.14–1.03; P =.06), compared with never-users, adjusting for covariates; ever HT use was not associated with distensibility. These findings were similar for women with and without HIV. Ever HT use was associated with lower serum D-dimer, but not with biomarkers of immune activation after covariate adjustment. Conclusions HT may confer a subclinical cardiovascular benefit in women with HIV. These results begin to fill a knowledge gap in menopausal care for women with HIV, in whom uptake of HT is very low. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Human Immunodeficiency Virus and Cardiac End-Organ Damage in Women: Findings From an Echocardiographic Study Across the United States.
- Author
-
Shitole, Sanyog G, Lazar, Jason M, Taub, Cynthia C, Furlani, Andrea C, Konkle-Parker, Deborah J, Dionne-Odom, Jodie, Fischl, Margaret A, Ofotokun, Igho, Adimora, Adaora A, Topper, Elizabeth F, Golzar, Yasmeen, Kassaye, Seble G, Gustafson, Deborah, Anastos, Kathryn, Hanna, David B, Xue, Xiaonan, Tien, Phyllis C, Kaplan, Robert C, and Kizer, Jorge R
- Subjects
- *
HIV infection complications , *CARDIOVASCULAR diseases risk factors , *ECHOCARDIOGRAPHY , *RELATIVE medical risk , *CONFIDENCE intervals , *LEFT ventricular dysfunction , *LEFT ventricular hypertrophy , *TRICUSPID valve diseases , *MULTIPLE organ failure , *CARDIOVASCULAR diseases , *RISK assessment , *DESCRIPTIVE statistics , *CD4 lymphocyte count , *LEFT heart atrium , *DISEASE risk factors - Abstract
Background People with human immunodeficiency virus (HIV) have been reported to have increased risk of clinical and subclinical cardiovascular disease. Existing studies have focused on men and often have been uncontrolled or lacked adequate HIV-negative comparators. Methods We performed echocardiography in the Women's Interagency HIV Study to investigate associations of HIV and HIV-specific factors with cardiac phenotypes, including left ventricular systolic dysfunction (LVSD), isolated LV diastolic dysfunction (LVDD), left atrial enlargement (LAE), LV hypertrophy (LVH), and increased tricuspid regurgitation velocity (TRV). Results Of 1654 participants (age 51 ± 9 years), 70% had HIV. Sixty-three (5.4%) women with HIV (WWH) had LVSD; 71 (6.5%) had isolated LVDD. Compared with women without HIV (WWOH), WWH had a near-significantly increased risk of LVSD (adjusted relative risk = 1.69; 95% confidence interval = 1.00 to 2.86; P =.051). No significant association was noted for HIV seropositivity with other phenotypes, but there was a risk gradient for decreasing CD4+ count among WWH that approached or reached significance for isolated LVDD, LAE, and LVH. WWH with CD4+ count <200 cells/mm3 had significantly higher prevalence of LAE, LVH, and high TRV than WWOH. There were no consistent associations for viral suppression or antiretroviral drug exposure. Conclusions This study suggests that WWH have a higher risk of LVSD compared with sociodemographically similar WWOH, but their risk for isolated LVDD, LAE, LVH, and high TRV is increased only with reduced CD4+ count. Although these findings warrant replication, they support the importance of cardiovascular risk-factor and HIV-disease control for heart disease prevention in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001–2012.
- Author
-
Hanna, David B., Ramaswamy, Chitra, Kaplan, Robert C., Kizer, Jorge R., Anastos, Kathryn, Daskalakis, Demetre, Zimmerman, Regina, and Braunstein, Sarah L.
- Subjects
- *
CARDIOVASCULAR diseases , *HIV , *HIV infections , *MORTALITY , *HIV-positive persons - Abstract
Background. Cardiovascular disease (CVD) has become more prominent among human immunodeficiency virus (HIV)-infected individuals. The extent to which CVD mortality rates are changing is unclear. Methods. We analyzed surveillance data for all persons aged ≥13 years with HIV infection between 2001 and 2012 reported to the New York City HIV Surveillance Registry. We examined age-specific and age-standardized mortality rates due to major CVDs. We compared mortality time trends among persons with HIV with the general population, and examined differences among HIV-infected persons by RNA level. Results. There were 29 588 deaths reported among 145 845 HIV-infected persons. Ten percent of deaths were attributed to CVD as the underlying cause, including chronic ischemic heart disease (42% of CVD deaths), hypertensive diseases (27%), and cerebrovascular diseases (10%). While proportionate mortality due to CVD among persons with HIV increased (6% in 2001 to 15% in 2012, P < .001), the CVD mortality rate decreased from 5.1 to 2.7 per 1000 person-years. After controlling for sex, race/ethnicity, borough of residence, and year, those with HIV had significantly higher CVD mortality than the general population in all age groups through age 65. The CVD mortality rate was highest among viremic persons (adjusted rate ratio [RR], 3.53 [95% confidence interval {CI}, 3.21-3.87]) but still elevated among virally suppressed (<400 copies/mL) persons (adjusted RR, 1.53 [95% CI, 1.41-1.66]) compared with the general population. Conclusions. Our findings support continued emphasis by HIV care providers on both viremic control and preventive measures including smoking cessation, blood pressure control, and lipid management. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
15. T-Cell Immune Dysregulation and Mortality in Women With Human Immunodeficiency Virus.
- Author
-
Peters, Brandilyn A, Moon, Jee-Young, Hanna, David B, Kutsch, Olaf, Fischl, Margaret, Moran, Caitlin A, Adimora, Adaora A, Gange, Stephen, Roan, Nadia R, Michel, Katherine G, Augenbraun, Michael, Sharma, Anjali, Landay, Alan, Desai, Seema, and Kaplan, Robert C
- Subjects
- *
HIV , *WOMEN'S mortality , *MONONUCLEAR leukocytes , *CD4 lymphocyte count , *T cells , *MORTALITY , *HIV infection complications , *DISEASE progression , *VIRAL load , *CARDIOVASCULAR diseases , *IMMUNOLOGY technique , *RESEARCH funding , *LONGITUDINAL method , *DISEASE complications - Abstract
Summary: In women with HIV, higher activation and exhaustion of CD4+ T cells were associated with risk of non-HIV-related mortality during a median of 13.3 years of follow-up, independent of baseline demographic, behavioral, HIV-related, and cardiometabolic factors and longitudinal HIV disease progression.Background: Dysregulation of adaptive immunity is a hallmark of human immunodeficiency virus (HIV) infection that persists on antiretroviral therapy (ART). Few long-term prospective studies have related adaptive immunity impairments to mortality in HIV, particularly in women.Methods: Among 606 women with HIV in the Women's Interagency HIV Study, peripheral blood mononuclear cells collected from 2002 to 2005 underwent multiparameter flow cytometry. Underlying cause of death was ascertained from the National Death Index up to 2018. We examined associations of CD4+ and CD8+ T-cell activation (%CD38+HLA-DR+), senescence (%CD57+CD28-), exhaustion (%PD-1+), and nonactivation/normal function (%CD57-CD28+) with natural-cause, HIV-related, and non-HIV-related mortality.Results: At baseline, median participant age was 41, and 67% were on ART. Among 100 deaths during a median of 13.3 years follow-up, 90 were natural-cause (53 non-HIV-related, 37 HIV-related). Higher activation and exhaustion of CD4+ T cells were associated with risk of natural-cause and non-HIV-related mortality, adjusting for age, demographic, behavioral, HIV-related, and cardiometabolic factors at baseline. Additional adjustment for time-varying viral load and CD4+ T-cell count did not attenuate these associations. CD8+ T-cell markers were not associated with any outcomes adjusting for baseline factors.Conclusions: Persistent CD4+ T-cell activation and exhaustion may contribute to excess long-term mortality risk in women with HIV, independent of HIV disease progression. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Menopause Is Associated With Immune Activation in Women With HIV.
- Author
-
Peters, Brandilyn A, Xue, Xiaonan, Sheira, Lila A, Qi, Qibin, Sharma, Anjali, Santoro, Nanette, Alcaide, Maria L, Ofotokun, Igho, Adimora, Adaora A, McKay, Heather S, Tien, Phyllis C, Michel, Katherine G, Gustafson, Deborah, Turan, Bulent, Landay, Alan L, Kaplan, Robert C, and Weiser, Sheri D
- Subjects
- *
TUMOR necrosis factor receptors , *HIV , *POSTMENOPAUSE , *MENOPAUSE , *CARRIER proteins - Abstract
Background: Persistent immune activation due to gut barrier dysfunction is a suspected cause of morbidity in HIV, but the impact of menopause on this pathway is unknown.Methods: In 350 women with HIV from the Women's Interagency HIV Study, plasma biomarkers of gut barrier dysfunction (intestinal fatty acid binding protein; IFAB), innate immune activation (soluble CD14 and CD163; sCD14, sCD163), and systemic inflammation (interleukin-6 and tumor necrosis factor receptor 1; IL-6, TNFR1) were measured at 674 person-visits spanning ≤2 years.Results: Menopause (post- vs premenopausal status) was associated with higher plasma sCD14 and sCD163 in linear mixed-effects regression adjusting for age and other covariates (β = 161.89 ng/mL; 95% confidence interval [CI], 18.37-305.41 and 65.48 ng/mL, 95% CI, 6.64-124.33, respectively); but not with plasma IFAB, IL-6, or TNFR1. In piece-wise linear mixed-effects regression of biomarkers on years before/after the final menstrual period, sCD14 increased during the menopausal transition by 250.71 ng/mL per year (95% CI, 16.63-484.79; P = .04), but not in premenopausal or postmenopausal periods.Conclusions: In women with HIV, menopause may increase innate immune activation, but data did not support an influence on the gut barrier or inflammation. Clinical implications of immune activation during menopausal transition warrant further investigation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. Mendelian randomization provides evidence for a causal effect of higher serum IGF-1 concentration on risk of hip and knee osteoarthritis.
- Author
-
Hartley, April, Sanderson, Eleanor, Paternoster, Lavinia, Teumer, Alexander, Kaplan, Robert C, Tobias, Jon H, and Gregson, Celia L
- Subjects
- *
HIP joint diseases , *KNEE diseases , *SOMATOMEDIN , *CONFIDENCE intervals , *CHEMILUMINESCENCE assay , *REGRESSION analysis , *RISK assessment , *IMMUNOASSAY , *OSTEOARTHRITIS , *GENOTYPES , *BODY mass index , *ODDS ratio , *WRIST , *SECONDARY analysis , *DISEASE risk factors - Abstract
Objectives How insulin-like growth factor-1 (IGF-1) is related to OA is not well understood. We determined relationships between IGF-1 and hospital-diagnosed hand, hip and knee OA in UK Biobank, using Mendelian randomization (MR) to determine causality. Methods Serum IGF-1 was assessed by chemiluminescent immunoassay. OA was determined using Hospital Episode Statistics. One-sample MR (1SMR) was performed using two-stage least-squares regression, with an unweighted IGF-1 genetic risk score as an instrument. Multivariable MR included BMI as an additional exposure (instrumented by BMI genetic risk score). MR analyses were adjusted for sex, genotyping chip and principal components. We then performed two-sample MR (2SMR) using summary statistics from Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) (IGF-1, N = 30 884) and the recent genome-wide association study meta-analysis (N = 455 221) of UK Biobank and Arthritis Research UK OA Genetics (arcOGEN). Results A total of 332 092 adults in UK Biobank had complete data. Their mean (s. d.) age was 56.5 (8.0) years and 54% were female. IGF-1 was observationally related to a reduced odds of hand OA [odds ratio per doubling = 0.87 (95% CI 0.82, 0.93)], and an increased odds of hip OA [1.04 (1.01, 1.07)], but was unrelated to knee OA [0.99 (0.96, 1.01)]. Using 1SMR, we found strong evidence for an increased risk of hip [odds ratio per s. d. increase = 1.57 (1.21, 2.01)] and knee [1.30 (1.07, 1.58)] OA with increasing IGF-1 concentration. By contrast, we found no evidence for a causal effect of IGF-1 concentration on hand OA [0.98 (0.57, 1.70)]. Results were consistent when estimated using 2SMR and in multivariable MR analyses accounting for BMI. Conclusion We have found evidence that increased serum IGF-1 is causally related to higher risk of hip and knee OA. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus.
- Author
-
Wang, Zheng, Usyk, Mykhaylo, Sollecito, Christopher C, Qiu, Yunping, Williams-Nguyen, Jessica, Hua, Simin, Gradissimo, Ana, Wang, Tao, Xue, Xiaonan, Kurland, Irwin J, Ley, Klaus, Landay, Alan L, Anastos, Kathryn, Knight, Rob, Kaplan, Robert C, Burk, Robert D, and Qi, Qibin
- Subjects
- *
FECAL analysis , *AMINO acids , *HIV , *HIV infections , *LIPIDS , *LIQUID chromatography , *MASS spectrometry , *METABOLISM , *METABOLITES , *NEUROTRANSMITTERS , *RNA , *WOMEN'S health , *GUT microbiome , *DESCRIPTIVE statistics , *METABOLOMICS - Abstract
Background Alterations in gut microbiota (GMB) and host metabolites have been noted in individuals with HIV. However, it remains unclear whether alterations in GMB and related functional groups contribute to disrupted host metabolite profiles in these individuals. Methods This study included 185 women (128 with longstanding HIV infection, 88% under antiretroviral therapy; and 57 women without HIV from the same geographic location with comparable characteristics). Stool samples were analyzed by 16S rRNA V4 region sequencing, and GMB function was inferred by PICRUSt. Plasma metabolomic profiling was performed using liquid chromatography–tandem mass spectrometry, and 133 metabolites (amino acids, biogenic amines, acylcarnitines, and lipids) were analyzed. Results Four predominant bacterial genera were identified as associated with HIV infection, with higher abundances of Ruminococcus and Oscillospira and lower abundances of Bifidobacterium and Collinsella in women with HIV than in those without. Women with HIV showed a distinct plasma metabolite profile, which featured elevated glycerophospholipid levels compared with those without HIV. Functional analyses also indicated that GMB lipid metabolism was enriched in women with HIV. Ruminococcus and Oscillospira were among the top bacterial genera contributing to the GMB glycerophospholipid metabolism pathway and showed positive correlations with host plasma glycerophospholipid levels. One bacterial functional capacity in the acetate and propionate biosynthesis pathway was identified to be mainly contributed by Bifidobacterium ; this functional capacity was lower in women with HIV than in women without HIV. Conclusions Our integrative analyses identified altered GMB with related functional capacities that might be associated with disrupted plasma metabolite profiles in women with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Loss of CXCR4 on non-classical monocytes in participants of the Women's Interagency HIV Study (WIHS) with subclinical atherosclerosis.
- Author
-
Mueller, Karin A L, Hanna, David B, Ehinger, Erik, Xue, Xiaonan, Baas, Livia, Gawaz, Meinrad P, Geisler, Tobias, Anastos, Kathryn, Cohen, Mardge H, Gange, Stephen J, Heath, Sonya L, Lazar, Jason M, Liu, Chenglong, Mack, Wendy J, Ofotokun, Igho, Tien, Phyllis C, Hodis, Howard N, Landay, Alan L, Kaplan, Robert C, and Ley, Klaus
- Subjects
- *
MONOCYTES , *CXCR4 receptors , *SYSTOLIC blood pressure , *HIV infections , *BLOOD cells - Abstract
Aims To test whether human immunodeficiency virus (HIV) infection and subclinical cardiovascular disease (sCVD) are associated with expression of CXCR4 and other surface markers on classical, intermediate, and non-classical monocytes in women. Methods and results sCVD was defined as presence of atherosclerotic lesions in the carotid artery in 92 participants of the Women's Interagency HIV Study (WIHS). Participants were stratified into four sets (n = 23 each) by HIV and sCVD status (HIV−/sCVD−, HIV−/sCVD+, HIV+/sCVD−, and HIV+/sCVD+) matched by age, race/ethnicity, and smoking status. Three subsets of monocytes were determined from archived peripheral blood mononuclear cells. Flow cytometry was used to count and phenotype surface markers. We tested for differences by HIV and sCVD status accounting for multiple comparisons. We found no differences in monocyte subset size among the four groups. Expression of seven surface markers differed significantly across the three monocyte subsets. CXCR4 expression [median fluorescence intensity (MFI)] in non-classical monocytes was highest among HIV−/CVD− [628, interquartile range (IQR) (295–1389)], followed by HIV+/CVD− [486, IQR (248–699)], HIV−/CVD+ (398, IQR (89–901)), and lowest in HIV+/CVD+ women [226, IQR (73–519)), P = 0.006 in ANOVA. After accounting for multiple comparison (Tukey) the difference between HIV−/CVD− vs. HIV+/CVD+ remained significant with P = 0.005 (HIV−/CVD− vs. HIV+/CVD− P = 0.04, HIV−/CVD− vs. HIV−/CVD+ P = 0.06, HIV+/CVD+ vs. HIV+/CVD− P = 0.88, HIV+/CVD+ vs. HIV−/CVD+ P = 0.81, HIV+/CVD− vs. HIV−/CVD+, P = 0.99). All pairwise comparisons with HIV−/CVD− were individually significant (P = 0.050 vs. HIV−/CVD+, P = 0.028 vs. HIV+/CVD−, P = 0.009 vs. HIV+/CVD+). CXCR4 expression on non-classical monocytes was significantly higher in CVD− (501.5, IQR (249.5–887.3)) vs. CVD+ (297, IQR (81.75–626.8) individuals (P = 0.028, n = 46 per group). CXCR4 expression on non-classical monocytes significantly correlated with cardiovascular and HIV−related risk factors including systolic blood pressure, platelet and T cell counts along with duration of antiretroviral therapy (P < 0.05). In regression analyses, adjusted for education level, study site, and injection drug use, presence of HIV infection and sCVD remained significantly associated with lower CXCR4 expression on non-classical monocytes (P = 0.003), but did not differ in classical or intermediate monocytes. Conclusion CXCR4 expression in non-classical monocytes was significantly lower among women with both HIV infection and sCVD, suggesting a potential atheroprotective role of CXCR4 in non-classical monocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. Association of Biomarker and Physiologic Indices With Mortality in Older Adults: Cardiovascular Health Study.
- Author
-
Sanders, Jason L, Arnold, Alice M, Boudreau, Robert M, Hirsch, Calvin H, Kizer, Jorge R, Kaplan, Robert C, Cappola, Anne R, Cushman, Mary, Jacob, Mini E, Kritchevsky, Stephen B, and Newman, Anne B
- Subjects
- *
BIOLOGICAL tags , *MORTALITY , *LONGEVITY , *PHENOTYPES , *PROPORTIONAL hazards models - Abstract
Background: A goal of gerontology is discovering aging phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that strongly and independently associated with mortality and that statistically attenuated chronologic age could be used to define such a phenotype. We determined the association of a Biomarker Index (BI) with mortality and compared it with a validated Physiologic Index (PI) in older adults.Methods: The indices were constructed in the Cardiovascular Health Study, mean (SD) age 74.5 (5.1) years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, insulin-like growth factor-binding protein 3, amino-terminal pro-B-type natriuretic peptide, dehydroepiandrosterone sulfate, and interleukin-6, and was built in test (N = 2,197) and validation (N = 1,124) samples. The PI included carotid intima-media thickness, pulmonary capacity, brain white matter grade, cystatin-C, and fasting glucose. Multivariable Cox proportional hazards models predicting death were calculated with 10 years of follow-up.Results: In separate age-adjusted models, the hazard ratio for mortality per point of the BI was 1.30 (95% confidence interval 1.25, 1.34) and the BI attenuated age by 25%. The hazard ratio for the PI was 1.28 (1.24, 1.33; 29% age attenuation). In the same model, the hazard ratio for the BI was 1.23 (1.18, 1.28) and for the PI was 1.22 (1.17, 1.26), and age was attenuated 42.5%. Associations persisted after further adjustment.Conclusions: The BI and PI were significantly and independently associated with mortality. Both attenuated the age effect on mortality substantially. The indices may be feasible phenotypes for developing interventions hoping to alter the trajectory of aging. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
21. Relationship of genetic determinants of height with cardiometabolic and pulmonary traits in the Hispanic Community Health Study/Study of Latinos.
- Author
-
Sofer, Tamar, Moon, Jee-Young, Isasi, Carmen R, Qi, Qibin, Shah, Neomi A, Kaplan, Robert C, and Kuniholm, Mark H
- Subjects
- *
CARDIOVASCULAR diseases , *INSULIN , *COHORT analysis , *DISEASES , *DEMOGRAPHY , *STATISTICS on Hispanic Americans , *CARDIOVASCULAR system , *CHOLESTEROL , *EXPERIMENTAL design , *GENETIC polymorphisms , *GENETICS , *GLOMERULAR filtration rate , *GLUCOSE tolerance tests , *HISPANIC Americans , *PUBLIC health , *RESEARCH funding , *RESPIRATORY measurements , *STATURE , *ETHNOLOGY research , *ANKLE brachial index , *SEQUENCE analysis , *STANDARDS - Abstract
Background: Associations of adult height with cardiometabolic and pulmonary traits have been studied in majority European ancestry populations using Mendelian randomization and polygenic risk score (PRS) analysis. The standard PRS approach entails creating a PRS for height using variants identified in prior genome-wide association studies (GWAS). It is unclear how well the standard PRS approach performs in non-European populations and whether height-trait associations observed in Europeans are also observed in other populations.Methods: In the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), we used: (i) the standard approach to create a PRS for height (PRS1) and (ii) a novel approach to optimize the selection of variants from previously established height association loci to better explain height in HCHS/SOL (PRS2). We also estimated the extent to which PRS-trait associations were independent or mediated by the PRS effect on height.Results: In 7539 women and 5245 men, PRS1 and PRS2 explained 9 and 29% of the variance in measured height, respectively. Both PRS1 and PRS2 were associated with forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/ FVC ratio, total cholesterol and 2-hour oral glucose-tolerance test insulin levels. Additionally, PRS2 was associated with estimated glomerular filtration rate and ankle brachial index. Both PRS1 and PRS2 had pleiotropic associations with FEV1/ FVC ratio in mediation analyses.Conclusions: Associations of polygenic scores of height with measures of lung function and cholesterol were consistent with those observed in prior studies of majority European ancestry populations. Mediation analysis may augment standard PRS approaches to disentangle pleiotropic and mediated effects. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
22. Trajectories of IGF-I Predict Mortality in Older Adults: The Cardiovascular Health Study.
- Author
-
Sanders, Jason L., Wensheng Guo, O'Meara, Ellen S., Kaplan, Robert C., Pollak, Michael N., Bartz, Traci M., Newman, Anne B., Fried, Linda P., Cappola, Anne R., and Guo, Wensheng
- Subjects
- *
SOMATOMEDIN C , *MORTALITY of older people , *CARDIOVASCULAR diseases in old age , *HOMEOSTASIS , *LIFE spans - Abstract
Background: Disruption of insulin-like growth factor-I (IGF-I) increases health and life span in animal models, though this is unconfirmed in humans. If IGF-I stability indicates homeostasis, the absolute level of IGF-I may be less clinically relevant than maintaining an IGF-I setpoint.Methods: Participants were 945 U.S. community-dwelling individuals aged ≥65 years enrolled in the Cardiovascular Health Study with IGF-I levels at 3-6 timepoints. We examined the association of baseline IGF-I level, trajectory slope, and variability around the trajectory with mortality.Results: There were 633 deaths over median 11.3 years of follow-up. Lower IGF-I levels, declining or increasing slope, and increasing variability were each individually associated with higher mortality (all p < .001). In an adjusted model including all three trajectory parameters, baseline IGF-I levels <70 ng/mL (hazard ratio [HR] 1.58, 95% CI 1.28-1.96 relative to IGF-I levels of 170 ng/mL), steep declines and steep increases in trajectory slope (HR 2.22, 1.30-3.80 for a 15% decline; HR 1.40, 1.07-1.84 for a 10% decline; HR 1.80, 1.12-2.89 for a 15% increase; HR 1.31, 1.00-1.72 for a 10% increase, each vs no change), and variability ≥10% (HR 1.59, 1.09-2.32 for ≥ 30%; HR 1.36, 1.06-1.75 for 20%; and HR 1.17, 1.03-1.32 for 10% variability, each vs 0%) in IGF-I levels were independently associated with mortality.Conclusions: In contrast to data from animal models, low IGF-I levels are associated with higher mortality in older humans. Irrespective of the actual IGF-I level, older individuals with stability of IGF-I levels have lower mortality than those whose IGF-I levels fluctuate over time. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
23. Concordance With Prevention Guidelines and Subsequent Cancer, Cardiovascular Disease, and Mortality: A Longitudinal Study of Older Adults.
- Author
-
Greenlee, Heather, Strizich, Garrett, Lovasi, Gina S., Kaplan, Robert C., Biggs, Mary L., Li, Christopher I., Richardson, John, Burke, Gregory L., Fitzpatrick, Annette L., Fretts, Amanda M., Psaty, Bruce M., and Fried, Linda P.
- Subjects
- *
CARDIOVASCULAR disease prevention , *BIOMARKERS , *CARDIOVASCULAR diseases , *CHRONIC diseases , *CONFIDENCE intervals , *HEALTH behavior , *LONGITUDINAL method , *REFERENCE books , *TUMORS , *LIFESTYLES , *DISEASE incidence , *ODDS ratio , *OLD age ,CARDIOVASCULAR disease related mortality ,TUMOR prevention - Abstract
Reports on the associations between multiple clinical and behavioral health indicators and major health outcomes among older adults are scarce. We prospectively examined concordance with guidelines from the American Cancer Society and American Heart Association for disease prevention in relation to cancer, cardiovascular disease (CVD), and mortality among Cardiovascular Health Study enrollees aged 65-98 years who, at baseline assessment in 1989-1996 (n = 3,491), were free of CVD and cancer. Total and cause-specific mortality, as well as incidence of cancer and CVD, were lower with higher guideline concordance. Independent of body mass index, blood pressure, total cholesterol, and fasting plasma glucose, better health behaviors (diet, physical activity, and alcohol consumption) were associated with lower mortality (2-sided P < 0.0001). Among individuals with ideal levels for 3-4 of these 4 cardiometabolic biomarkers, those with poor concordance with health behavior recommendations had higher mortality compared with those who had the highest concordance with these behavioral recommendations (adjusted mortality hazard ratio = 1.82,95% confidence interval: 1.25,2.67). Older adults who are concordant with recommendations for cancer and CVD prevention have reduced rates of chronic disease and mortality. Interventions to achieve and maintain healthy lifestyle behaviors may offer benefits both in the presence and absence of adverse traditional clinical risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.
- Author
-
Franceschini, Nora, Yu Deng, Flessner, Michael F., Eckfeldt, John H., Kramer, Holly J., Lash, James P., Lee, David J., Melamed, Michal L., Moncrieft, Ashley E., Ricardo, Ana C., Rosas, Sylvia E., Kaplan, Robert C., Raij, Leopoldo, and Cai, Jianwen
- Subjects
- *
SMOKING , *CHRONIC kidney failure , *CREATININE , *CIGARETTE smokers , *PATIENTS , *DISEASE risk factors - Abstract
Background. Intermittent smoking is prevalent amongHispanics, but little is known about whether this smoking pattern associates with increased chronic kidney disease (CKD) risk in this population. The objective of the present study is to identify patterns of exposure associated with CKD in US Hispanics. Methods. We used cross-sectional data on 15 410 participants of the Hispanics Community Health Study/the Study of Latinos, a population-based study of individuals aged 18-74 years, recruited in 2008 to 2011 from four US field centers (Bronx, NY; Chicago, IL; Miami, FL; San Diego, CA). Smoking exposure was obtained through a questionnaire. CKD was defined by an estimated glomerular filtration rate of <60 mL/min/ 1.73 m² or a urine albumin-to-creatinine ratio of ≥30 mg/g. Results. Approximately 14% of individuals were daily and 7% were intermittent smokers, and 16% were past smokers. There was a significant interaction between smoking status and packyears of exposure (P = 0.0003). In adjusted models, therewas an increased odds of CKD among daily, intermittent and past smokers by pack-years compared with never smokers. The association of intermittent smokers was significant at 10 pack-years [odds ratio (OR) = 1.38, 95% confidence intervals (CI) 1.06, 1.81], whereas for daily smokers this association was observed at 40 pack-years (OR = 1.43, 95% CI 1.09, 1.89). Conclusions. Our findings of increased risk of CKD among Hispanics who are intermittent smokers support screening and smoking cessation interventions targeted to this population for the prevention of CKD. It also suggests novel mechanistic pathways for kidney toxicity that should be further explored in future studies. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
25. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.
- Author
-
Hanna, David B., Mengye Guo, ková, Petra Bu°, Miller, Tracie L., Post, Wendy S., Stein, James H., Currier, Judith S., Kronmal, Richard A., Freiberg, Matthew S., Bennett, Siiri N., Shikuma, Cecilia M., Anastos, Kathryn, Yanjie Li, Tracy, Russell P., Hodis, Howard N., Delaney, Joseph A., and Kaplan, Robert C.
- Subjects
- *
THERAPEUTICS , *HIV infections , *ATHEROSCLEROSIS , *CAROTID artery diseases , *ULTRASONIC imaging , *BIFURCATION theory - Abstract
Background. Age and human immunodeficiency virus (HIV) treatment may affect the association of HIV infection with atherosclerosis. Methods. We used identical carotid artery B-mode ultrasonographic methods in 5 cohorts participating in the National Heart, Lung, and Blood Institute HIV-CVD Collaborative to measure intima-media thickness of the right far wall of the common carotid artery (CCA-IMT) and carotid artery bifurcation (BIF-IMT) between 2010 and 2013. Participants aged 6-75 years were either HIV infected or uninfected. Linear regression assessed associations of CCA-IMT and BIF-IMT with HIV infection and cardiovascular disease risk factors, within age and HIV treatment groups. Adjustment variables included sex, race/ethnicity, smoking, height, weight, and use of antihypertensive and lipid-lowering drugs. Results. We studied 867 HIV-infected and 338 HIV-uninfected male and 696 HIV-infected and 246 HIV-uninfected female participants. Among both middle-aged (30-49 years) and older adults (50-75 years), HIV-infected participants had CCA-IMT and BIFIMT values that were similar to or lower than those in HIV-uninfected participants. In contrast, among those aged 6-29 years, HIV infection was associated with higher CCA-IMT and BIF-IMT values. Among HIV-infected participants, associations of higher systolic blood pressure and lower high-density lipoprotein cholesterol with Carotid artery intima-media thickness strengthened with age. Conclusions. The effects of HIV on carotid artery structure may differ across the lifespan, with traditional determinants of cardiovascular disease burden playing a larger role and HIV playing a lesser role in older adults than in young adults and children. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
26. Local Ancestry Inference in a Large US-Based Hispanic/Latino Study: Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
- Author
-
Browning, Sharon R., Grinde, Kelsey, Plantinga, Anna, Gogarten, Stephanie M., Stilp, Adrienne M., Kaplan, Robert C., Avilés-Santa, M. Larissa, Browning, Brian L., and Laurie, Cathy C.
- Subjects
- *
GENETIC genealogy , *X chromosome , *HISPANIC Americans - Abstract
We estimated local ancestry on the autosomes and X chromosome in a large US-based study of 12,793 Hispanic/Latino individuals using the RFMix method, and we compared different reference panels and approaches to local ancestry estimation on the X chromosome by means of Mendelian inconsistency rates as a proxy for accuracy. We developed a novel and straightforward approach to performing ancestry-specific PCA after finding artifactual behavior in the results from an existing approach. Using the ancestry-specific PCA, we found significant population structure within African, European, and Amerindian ancestries in the Hispanic/Latino individuals in our study. In the African ancestral component of the admixed individuals, individuals whose grandparents were from Central America clustered separately from individuals whose grandparents were from the Caribbean, and also from reference Yoruba and Mandenka West African individuals. In the European component, individuals whose grandparents were from Puerto Rico diverged partially from other background groups. In the Amerindian ancestral component, individuals clustered into multiple different groups depending on the grandparental country of origin. Therefore, local ancestry estimation provides further insight into the complex genetic structure of US Hispanic/Latino populations, which must be properly accounted for in genotype-phenotype association studies. It also provides a basis for admixture mapping and ancestry-specific allele frequency estimation, which are useful in the identification of risk factors for disease. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
27. Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.
- Author
-
Brutsaert, Erika F., Shitole, Sanyog, Biggs, Mary Lou, Mukamal, Kenneth J., deBoer, Ian H., Thacker, Evan L., Barzilay, Joshua I., Djoussé, Luc, Ix, Joachim H., Smith, Nicholas L., Kaplan, Robert C., Siscovick, David S., Psaty, Bruce M., and Kizer, Jorge R.
- Subjects
- *
DISEASE incidence , *BLOOD sugar , *HYPERGLYCEMIA , *DISEASE prevalence , *HEALTH of older people , *AGING , *CARDIOVASCULAR diseases , *FASTING , *GLUCOSE , *GLUCOSE tolerance tests , *LONGITUDINAL method , *RESEARCH funding , *RISK assessment , *SURVEYS , *SURVIVAL , *PROPORTIONAL hazards models ,CARDIOVASCULAR disease related mortality - Abstract
Background: Older adults have a high prevalence of postload hyperglycemia. Postload glucose has shown more robust associations with cardiovascular disease (CVD) and death than fasting glucose, but data in the oldest old are sparse.Methods: Fasting and 2-hour postload glucose were measured in community-dwelling older adults, mean age 78, at the 1996-1997 follow-up visit of the Cardiovascular Health Study. We evaluated their associations with atherosclerotic CVD (ASCVD) and mortality using standard Cox regression and competing-risks analyses and assessed improvement in prediction-model discrimination with the c-statistic.Results: Among 2,394 participants without treated diabetes and available data on glycemic measures, there were 579 ASCVD events and 1,698 deaths during median follow-up of 11.2 years. In fully adjusted models, both fasting and 2-hour glucose were associated with ASCVD (HR per SD, 1.13 [1.03-1.25] and 1.17 [1.07-1.28], respectively) and all-cause mortality (HR 1.12 [1.07-1.18] and 1.14 [1.08-1.20]). After mutual adjustment, however, the associations for fasting glucose with both outcomes were abolished, but those for postload glucose were largely unchanged. Consistent findings were observed for ASCVD in competing-risks models.Conclusion: In adults surviving to advanced old age, postload glucose was associated with ASCVD and mortality independently of fasting glucose, but fasting glucose was not associated with these outcomes independently of postload glucose. These findings affirm the robust association of postload glucose with ASCVD and death late in life. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
28. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
- Author
-
Gunter, Marc J., Tao Wang, Cushman, Mary, Xiaonan Xue, Wassertheil-Smoller, Sylvia, Strickler, Howard D., Rohan, Thomas E., Manson, JoAnn E., McTiernan, Anne, Kaplan, Robert C., Scherer, Philipp E., Chlebowski, Rowan T., Snetselaar, Linda, Wang, Dan, Ho, Gloria Y. F., Wang, Tao, and Xue, Xiaonan
- Subjects
- *
OBESITY complications , *BLOOD coagulation factors , *BREAST tumors , *C-reactive protein , *CYTOKINES , *ESTRADIOL , *INFLAMMATION , *INSULIN , *INTERLEUKINS , *LONGITUDINAL method , *OBESITY , *PEPTIDE hormones , *RESEARCH funding , *RISK assessment , *TUMOR markers , *TUMOR necrosis factors , *LEPTIN , *BODY mass index , *PROPORTIONAL hazards models , *POSTMENOPAUSE , *ADIPONECTIN , *ODDS ratio , *DISEASE complications - Abstract
Background: Adipokines and inflammation may provide a mechanistic link between obesity and postmenopausal breast cancer, yet epidemiologic data on their associations with breast cancer risk are limited.Methods: In a case-cohort analysis nested within the Women's Health Initiative Observational Study, a prospective cohort of postmenopausal women, baseline plasma samples from 875 incident breast cancer case patients and 839 subcohort participants were tested for levels of seven adipokines, namely leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α, hepatocyte growth factor, and plasminogen activator inhibitor-1, and for C-reactive protein (CRP), an inflammatory marker. Data were analyzed by multivariable Cox modeling that included established breast cancer risk factors and previously measured estradiol and insulin levels. All statistical tests were two-sided.Results: The association between plasma CRP levels and breast cancer risk was dependent on hormone therapy (HT) use at baseline (P interaction = .003). In a model that controlled for multiple breast cancer risk factors including body mass index (BMI), estradiol, and insulin, CRP level was positively associated with breast cancer risk among HT nonusers (hazard ratio for high vs low CRP levels = 1.67, 95% confidence interval = 1.04 to 2.68, P trend = .029). None of the other adipokines were statistically significantly associated with breast cancer risk. Following inclusion of CRP, insulin, and estradiol in a multivariable model, the association of BMI with breast cancer was attenuated by 115%.Conclusion: These data indicate that CRP is a risk factor for postmenopausal breast cancer among HT nonusers. Inflammatory mediators, together with insulin and estrogen, may play a role in the obesity-breast cancer relation. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
29. HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis.
- Author
-
Hanna, David B., Post, Wendy S., Deal, Jennifer A., Hodis, Howard N., Jacobson, Lisa P., Mack, Wendy J., Anastos, Kathryn, Gange, Stephen J., Landay, Alan L., Lazar, Jason M., Palella, Frank J., Tien, Phyllis C., Witt, Mallory D., Xiaonan Xue, Young, Mary A., Kaplan, Robert C., and Kingsley, Lawrence A.
- Subjects
- *
HIV infection complications , *ATHEROSCLEROSIS risk factors , *DISEASE progression , *CAROTID artery diseases , *ATHEROSCLEROTIC plaque , *CD4 lymphocyte count - Abstract
Background. Individuals infected with human immunodeficiency virus (HIV) live longer as a result of effective treatment, but long-term consequences of infection, treatment, and immunological dysfunction are poorly understood. Methods. We prospectively examined 1011 women (74% HIV-infected) in theWomen's Interagency HIV Study and 811 men (65% HIV-infected) in the Multicenter AIDS Cohort Study who underwent repeated B-mode carotid artery ultrasound imaging in 2004-2013. Outcomes included changes in right common carotid artery intima-media thickness (CCA-IMT) and new focal carotid artery plaque formation (IMT >1.5 mm) over median 7 years. We assessed the association between HIV serostatus and progression of subclinical atherosclerosis, adjusting for demographic, behavioral, and cardiometabolic risk factors. Results. Unadjusted mean CCA-IMT increased (725 to 752 µm in women, 757 to 790 µm in men), but CCAIMT progression did not differ by HIV serostatus, either in combined or sex-specific analyses. Focal plaque prevalence increased from 8% to 15% in women and 25% to 34% in men over 7 years. HIV-infected individuals had 1.6-fold greater risk of new plaque formation compared with HIV-uninfected individuals (relative risk [RR] 1.61, 95% CI, 1.12-2.32), adjusting for cardiometabolic factors; the association was similar by sex. Increased plaque occurred even among persistently virologically suppressed HIV-infected individuals compared with uninfected individuals (RR 1.56, 95% CI, 1.07-2.27). HIV-infected individuals with baseline CD4+ ≥500 cells/μL had plaque risk not statistically different from uninfected individuals. Conclusions. HIV infection is associated with greater increases in focal plaque among women and men, potentially mediated by factors associated with immunodeficiency or HIV replication at levels below current limits of detection. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy.
- Author
-
Broer, Linda, Buchman, Aron S, Deelen, Joris, Evans, Daniel S, Faul, Jessica D, Lunetta, Kathryn L, Sebastiani, Paola, Smith, Jennifer A, Smith, Albert V, Tanaka, Toshiko, Yu, Lei, Arnold, Alice M, Aspelund, Thor, Benjamin, Emelia J, De Jager, Philip L, Eirkisdottir, Gudny, Evans, Denis A, Garcia, Melissa E, Hofman, Albert, and Kaplan, Robert C
- Abstract
Background: The genetic contribution to longevity in humans has been estimated to range from 15% to 25%. Only two genes, APOE and FOXO3, have shown association with longevity in multiple independent studies.Methods: We conducted a meta-analysis of genome-wide association studies including 6,036 longevity cases, age ≥90 years, and 3,757 controls that died between ages 55 and 80 years. We additionally attempted to replicate earlier identified single nucleotide polymorphism (SNP) associations with longevity.Results: In our meta-analysis, we found suggestive evidence for the association of SNPs near CADM2 (odds ratio [OR] = 0.81; p value = 9.66 × 10(-7)) and GRIK2 (odds ratio = 1.24; p value = 5.09 × 10(-8)) with longevity. When attempting to replicate findings earlier identified in genome-wide association studies, only the APOE locus consistently replicated. In an additional look-up of the candidate gene FOXO3, we found that an earlier identified variant shows a highly significant association with longevity when including published data with our meta-analysis (odds ratio = 1.17; p value = 1.85×10(-10)).Conclusions: We did not identify new genome-wide significant associations with longevity and did not replicate earlier findings except for APOE and FOXO3. Our inability to find new associations with survival to ages ≥90 years because longevity represents multiple complex traits with heterogeneous genetic underpinnings, or alternatively, that longevity may be regulated by rare variants that are not captured by standard genome-wide genotyping and imputation of common variants. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
31. Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies.
- Author
-
Kuniholm, Mark H, Jung, Molly, Everhart, James E, Cotler, Scott, Heiss, Gerardo, McQuillan, Geraldine, Kim, Ryung S, Strickler, Howard D, Thyagarajan, Bharat, Youngblood, Marston, Kaplan, Robert C, and Ho, Gloria Y F
- Abstract
Prevalence of hepatitis C virus (HCV) antibody has been reported in Mexican Americans, but its prevalence in other US Hispanic/Latino groups is unknown. We studied 2 populations of US Hispanic/Latino adults; 3210 from the National Health and Nutrition Examination Survey (NHANES) 2007-2010 and 11 964 from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Age-standardized prevalence of HCV antibody was similar in NHANES 2007-2010 (1.5%) and HCHS/SOL (2.0%) but differed significantly by Hispanic/Latino background in HCHS/SOL (eg, 11.6% in Puerto Rican men vs 0.4% in South American men). These findings suggest that the HCV epidemic among US Hispanics/Latinos is heterogeneous. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
32. Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results From the NHANES 2007–2010 and HCHS/SOL Studies.
- Author
-
Kuniholm, Mark H., Jung, Molly, Everhart, James E., Cotler, Scott, Heiss, Gerardo, McQuillan, Geraldine, Kim, Ryung S., Strickler, Howard D., Thyagarajan, Bharat, Youngblood, Marston, Kaplan, Robert C., and Ho, Gloria Y. F.
- Subjects
- *
HEPATITIS C transmission , *HISPANIC Americans , *DISEASE prevalence , *HEPATITIS , *HEALTH of Mexican Americans , *DISEASES , *DISEASE risk factors - Abstract
Prevalence of hepatitis C virus (HCV) antibody has been reported in Mexican Americans, but its prevalence in other US Hispanic/Latino groups is unknown. We studied 2 populations of US Hispanic/Latino adults; 3210 from the National Health and Nutrition Examination Survey (NHANES) 2007–2010 and 11 964 from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Age-standardized prevalence of HCV antibody was similar in NHANES 2007–2010 (1.5%) and HCHS/SOL (2.0%) but differed significantly by Hispanic/Latino background in HCHS/SOL (eg, 11.6% in Puerto Rican men vs 0.4% in South American men). These findings suggest that the HCV epidemic among US Hispanics/Latinos is heterogeneous. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
33. Do Changes in Circulating Biomarkers Track With Each Other and With Functional Changes in Older Adults?
- Author
-
Sanders, Jason L., Ding, Victoria, Arnold, Alice M., Kaplan, Robert C., Cappola, Anne R., Kizer, Jorge R., Boudreau, Robert M., Cushman, Mary, and Newman, Anne B.
- Subjects
- *
GERONTOLOGY research , *FUNCTIONAL loss in older people , *ACTIVITIES of daily living , *GERIATRIC assessment , *BIOMARKERS , *EPIDEMIOLOGICAL research , *INFLAMMATION - Abstract
Background. It is unclear if changes in proposed circulating biomarkers of aging are strongly correlated to each other or functional change. We tested if biomarker changes track with each other and with functional measures over 9 years in older adults. Methods. Dehydroepiandrosterone sulfate (DHEAS), adiponectin, insulin-like growth factor 1 (IGF-1), IGF binding proteins 1 (IGFBP-1) and 3 (IGFBP-3), interleukin-6 (IL-6), cholesterol, and function (gait speed, grip strength, Modified Mini Mental Status Exam [3MSE] and Digit Symbol Substitution Test [DSST] scores) were measured in 1996–1997 and 2005–2006 in the Cardiovascular Health Study All Stars study (N = 901, mean [standard deviation, SD] age 85.3 [3.6] years in 2005–2006). Adjusted Pearson correlations illustrated if biomarkers tracked together. Multivariable linear regression demonstrated if biomarker changes tracked with functional changes. Results. Correlations among biomarker changes were mostly <0.2. In models with each biomarker entered separately, a 1-SD increase biomarker change was associated with change in function as follows: grip strength (DHEAS β = 0.61kg, p = .001; IL-6 β = −0.46kg, p = .012; cholesterol men β = 0.79kg, p = .016); gait speed (DHEAS β = 0.02 meters per second, p = .039; IL-6 β = −0.018 meters per second, p = .049); and DSST score (DHEAS women β = 1.46, p = .004; IL-6 β = −0.83, p = .027). When biomarkers were entered in the same model, significant associations remaining were as follows: grip strength (DHEAS β = 0.54kg, p = .005; IL-6 β = −0.43kg, p = .022); 3MSE score (IGF-1 β = 0.96, p = .04; IGFBP-3 β = −1.07, p = .024); and DSST score (DHEAS women β = 1.27, p = .012; IL-6 β = −0.80, p = .04). Conclusion. Changes in biomarkers were poorly correlated, supporting a model of stochastic, independent change across systems. DHEAS and IL-6 tracked most closely with function, illustrating that changes in inflammation and sex steroids may play dominant roles in changes of these functional outcomes. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
34. Cytomegalovirus Immunoglobulin G Antibody Is Associated With Subclinical Carotid Artery Disease Among HIV-Infected Women.
- Author
-
Parrinello, Christina M., Sinclair, Elizabeth, Landay, Alan L., Lurain, Nell, Sharrett, A. Richey, Gange, Stephen J., Xue, Xiaonan, Hunt, Peter W., Deeks, Steven G., Hodis, Howard N., and Kaplan, Robert C.
- Subjects
- *
CYTOMEGALOVIRUSES , *IMMUNOGLOBULIN G , *CAROTID artery diseases , *VASCULAR diseases , *HIV-positive women , *MULTIVARIATE analysis - Abstract
Background. Cytomegalovirus (CMV) infection has been implicated in immune activation and accelerated progression of immunodeficiency from human immunodeficiency virus (HIV) coinfection. We hypothesized that CMV is associated with vascular disease in HIV-infected adults.Methods. In the Women's Interagency HIV Study, we studied 601 HIV-infected and 90 HIV-uninfected participants. We assessed the association of CMV immunoglobulin G (IgG) level with carotid artery intima-media thickness, carotid artery distensibility, Young's elastic modulus, and blood pressures. Multivariable models adjusted for age, race/ethnicity, smoking, diabetes, and body mass index.Results. Mean CMV IgG levels were higher in HIV-infected women compared with HIV-uninfected women (P < .01). Among HIV-infected women, higher CMV IgG level was associated with decreased carotid artery distensibility (P < .01) and increased Young's modulus (P = .02). Higher CMV IgG antibody level was associated with increased prevalence of carotid artery lesions among HIV-infected women who achieved HIV suppression on antiretroviral therapy, but not among viremic or untreated HIV-infected women. Adjustment for Epstein–Barr virus antibody levels and C-reactive protein levels had no effect on the associations between CMV IgG levels and vascular parameters.Conclusions. Cytomegalovirus antibody titers are increased in HIV-infected women and associated with subclinical cardiovascular disease. Host responses to CMV may be abnormal in HIV infection and associated with clinical disease. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
35. Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women.
- Author
-
Gunter, Marc J., Hoover, Donald R., Yu, Herbert, Wassertheil-Smoller, Sylvia, Rohan, Thomas E., Manson, JoAnn E., Jixin Li, Ho, Gloria Y.F., Xiaonan Xue, Anderson, Garnet L., Kaplan, Robert C., Harris, Tiffany G., Howard, Barbara V., Wylie-Rosett, Judith, Burk, Robert D., and Strickler, Howard D.
- Subjects
- *
SOMATOMEDIN , *INSULIN , *BREAST cancer , *OBESITY , *ESTROGEN , *ADIPOSE tissues - Abstract
Background The positive association between obesity and postmenopausal breast cancer has been attributed, in part, to the fact that estrogen, a risk factor for breast cancer, is synthesized in adipose tissue. Obesity is also associated with high levels of insulin, a known mitogen. However, no prospective studies have directly assessed associations between circulating levels of insulin and/or insulin-like growth factor (IGF)-l, a related hormone, and the risk of breast cancer independent of estrogen level. Methods We conducted a case-cohort study of incident breast cancer among nondiabetic women who were enrolled in the Women's Health Initiative Observational Study (WHI-OS), a prospective cohort of 93676 postmenopausal women. Fasting serum samples obtained at study entry from 835 incident breast cancer case subjects and from a subcohort of 816 randomly chosen WHI-OS subjects were tested for levels of insulin, glucose, total IGF-l, free IGF-l, insulin-like growth factor binding protein-3, and estradiol. Multivariable Cox proportional hazards models were used to estimate associations between levels of the serologic factors and baseline characteristics (including body mass index IBMI]) and the risk of breast cancer. All statistical tests were two-sided. Results Insulin levels were positively associated with the risk of breast cancer (hazard ratio [HR] for highest vs lowest quartile of insulin level = 1.46, 95% confidence interval [Cl] = 1.00 to 2.13, Ptrend = .02); however, the association with insulin level varied by hormone therapy (HT) use (Pintersection = .01). In a model that controlled for multiple breast cancer risk factors including estradiol, insulin level was associated with breast cancer only among nonusers of HT (HR for highest vs lowest quartile of insulin level = 2.40, 95% CI = 1.30 to 4.41, Ptrend < .001). Obesity (BMI ≥30 kg/m²) was also associated with the risk of breast cancer among nonusers of HT (HR for BMI ≥30 kg/m² vs 18.5 to <25 kg/m² = 2.12, 95% Cl = 1.26 to 3.58, Ptrend =.003); however, this association was attenuated by adjustment for insulin (Ptrend = .40). Conclusion These data suggest that hyperinsulinemia is an independent risk factor for breast cancer and may have a substantial role in explaining the obesity-breast cancer relationship. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
36. Associations of Insulin-Like Growth Factor (IGF)—I and IGF-Binding Protein—3 with HIV Disease Progression in Women.
- Author
-
Strickler, Howard D., Fazzari, Melissa, Kovacs, Andrea, Lsasi, Carmen, Napolitano, Laura A., Minkoff, Howard, Gange, Stephen, Mary Young, Sharp, Gerald B., Kaplan, Robert C., Cohen, Mardge, Gunter, Marc J., Harris, Tiffany G., Herbert Yu, Schoenbaum, Ellie, Landay, Alan L., and Anastos, Kathryn
- Subjects
- *
SOMATOMEDIN , *HIV , *LYMPHOCYTES , *INSULIN-like growth factor-binding proteins , *STEM cells , *ANTIRETROVIRAL agents - Abstract
Background. The insulin-like growth factor (IGF) axis has been hypothesized to influence the rate of human immunodeficiency virus (HIV) disease progression. This premise is based largely on laboratory models showing that IGF-l stimulates thymic growth and increases lymphocyte numbers and that IGF-binding protein (IGFBP)-3 has an opposing effect, inhibiting heniatopoietic stem cell development. Methods. We studied 1422 HIV-infected women enrolled in a large cohort that entailed semiannual follow-up (initiated in 1994). Baseline serum samples were tested for IGF-l and IGFBP-3 to determine their associations with incident clinical acquired immunodeficiency syndrome (AIDS) and CD4+ T cell count decline prior to April 1996 (before the era of highly active antiretroviral therapy [HAART]). Results. Low IGF-I levels (Ptrend = .02) and high IGFBP-3 levels (Ptrend = .02) were associated with rapid CD4+ T cell count decline. Only IGFBP-3, however, was significantly associated with AIDS incidence (hazard ratio for highest vs. lowest quartile, 2.65 [95% confidence interval, 1.30-5.421; Ptrend = .02) in multivariable models. Conclusions. These findings suggest that serum levels of IGFBP-3 (and possibly IGF-I) are associated with the rate of HIV disease progression in women and, more broadly, that interindividual heterogeneity in the IGE axis may influence HIV pathogenesis. If correct, the IGF axis could be a target for interventions to slow HIV disease progression and extend the time before use of HAART becomes necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
37. Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection.
- Author
-
Shan, Zhilei, Clish, Clary B, Hua, Simin, Scott, Justin M, Hanna, David B, Burk, Robert D, Haberlen, Sabina A, Shah, Sanjiv J, Margolick, Joseph B, Sears, Cynthia L, Post, Wendy S, Landay, Alan L, Lazar, Jason M, Hodis, Howard N, Anastos, Kathryn, Kaplan, Robert C, and Qi, Qibin
- Abstract
We examined associations of 5 plasma choline metabolites with carotid plaque among 520 HIV-infected and 217 HIV-uninfected participants (112 incident plaque cases) over 7 years. After multivariable adjustment, higher gut microbiota-related metabolite trimethylamine-N-oxide (TMAO) was associated with an increased risk of carotid plaque in HIV-infected participants (risk ratio = 1.25 per standard deviation increment; 95% confidence interval, 1.05-1.50; P = .01). TMAO was positively correlated with biomarkers of monocyte activation and inflammation (sCD14, sCD163). Further adjustment for these biomarkers attenuated the association between TMAO and carotid plaque (P = .08). Among HIV-infected individuals, plasma TMAO was associated with carotid atherosclerosis progression, partially through immune activation and inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.